A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This is non randomised, open label, dose finding, efficacy and safety study, enrolling
patients with advanced (stage III and IV) ovarian cancer It will be conducted in two
successive phases. Phase II has a two-step design